Search

everythinglearnresearchcommunity

for

Search:↓

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Using a combination of AMD3100 and FK506 can speed up and improve wound healing in diabetic rats.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Cyclophosphamide effectively induces cashmere shedding in goats without affecting their overall health.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Caribine from traditional Chinese medicine may help treat hair loss.

The new ELISA method is reliable and eco-friendly for checking the quality of Pueraria candollei.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Microneedle delivery of a special collagen shows promise for treating hair loss.

Farudodstat may effectively treat alopecia areata without harmful side effects.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.